New concepts in systemic autoimmunity testing

Area of Science:

• Clinical immunology
• Autoimmune disease diagnostics
• Laboratory automation

Background:

• Diagnosing systemic autoimmune diseases is complex due to variable autoantibody assay results.
• A standardized "gold standard" is needed for early differentiation of autoimmune phenomena.
• Current methods lack interchangeability, hindering reliable diagnosis.

Purpose of the Study:

• To introduce a novel Rheuma Entrance Screening (RES) assay toolbox for standardized autoimmune disease diagnostics.
• To address the challenge of non-interchangeable assay systems in autoantibody testing.
• To provide a reliable screening method for early detection of systemic rheumatic diseases.

Main Methods:

• Development of a Rheuma Entrance Screening (RES) assay toolbox using fully-automated enzyme immunoassay (EIA) technology.
• Application of EIA on the COBAS CORE analyser for simultaneous testing of key analytes.
• Inclusion of anti-nuclear antibodies (ANA), rheumatoid factor (RF), C-reactive protein (CRP), and anti-beta-2 glycoprotein I (anti-beta2 GPI) testing.

Main Results:

• The RES toolbox offers an objective, rapid, and reproducible method for screening autoantibodies.
• Standardization of results across different assay systems is achieved.
• Efficient screening for patients suspected of systemic rheumatic diseases is enabled.

Conclusions:

• The proposed RES assay toolbox, utilizing automated EIA, can overcome current diagnostic challenges in autoimmune diseases.
• This approach facilitates early and accurate differentiation of significant autoimmune conditions.
• The RES toolbox serves as a valuable screening tool for routine clinical laboratories.